Source: Cardiology. Unidade: FM
Subjects: BETA-BLOQUEADORES (TENDÊNCIAS), FÁRMACOS (SISTEMA CARDIOVASCULAR), INSUFICIÊNCIA CARDÍACA (FISIOPATOLOGIA)
ABNT
BOCCHI, Edimas Alcides et al. Effect of Combining Ivabradine and β-Blockers: Focus on the Use of Carvedilol in the SHIFT Population. Cardiology, v. 131, n. 4, p. 218-224, 2015Tradução . . Disponível em: https://doi.org/10.1159/000380812. Acesso em: 06 nov. 2024.APA
Bocchi, E. A., Böhm, M., Borer, J. S., Ford, I., Komajda, M., Swedberg, K., & Tavazzi, L. (2015). Effect of Combining Ivabradine and β-Blockers: Focus on the Use of Carvedilol in the SHIFT Population. Cardiology, 131( 4), 218-224. doi:10.1159/000380812NLM
Bocchi EA, Böhm M, Borer JS, Ford I, Komajda M, Swedberg K, Tavazzi L. Effect of Combining Ivabradine and β-Blockers: Focus on the Use of Carvedilol in the SHIFT Population [Internet]. Cardiology. 2015 ; 131( 4): 218-224.[citado 2024 nov. 06 ] Available from: https://doi.org/10.1159/000380812Vancouver
Bocchi EA, Böhm M, Borer JS, Ford I, Komajda M, Swedberg K, Tavazzi L. Effect of Combining Ivabradine and β-Blockers: Focus on the Use of Carvedilol in the SHIFT Population [Internet]. Cardiology. 2015 ; 131( 4): 218-224.[citado 2024 nov. 06 ] Available from: https://doi.org/10.1159/000380812